Technical Development Leader
Roche Diagnostics GmbH
Eva Rosenberg is an accomplished Technical Development Leader in the field of Biologics Drug Development. In her role, she is responsible for defining and driving the CMC (chemistry, manufacturing & controls) development strategies for several products across the Roche portfolio, from clinical development to commercialization. Amongst recent accomplishments is the clinical development of an ocular drug-device combination product.
Before her current position, Eva served as a Late Stage Technical Leader for Drug Substance (DS) of several monoclonal antibodies and related formats. Eva's expertise extended to clinical and commercial DS development and manufacturing, including BioProcess transfers to commercial manufacturing sites. She also demonstrated a deep understanding of CMC guidelines, quality standards, and regulatory requirements.
Disclosure information not submitted.
Biologics Summit Part II Morning Session
Monday, July 8, 2024
9:00 AM – 12:00 PM CET
Biologics Summit Part II Afternoon Session
Monday, July 8, 2024
1:00 PM – 2:30 PM CET